4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-044020
President & CEO sold 12,000 shares at $95.09 ($1,141,080)
- President & CEO acquired 12,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hassanein Waleed H · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,000 | $13.28 | $159,360 | 86,087 | D |
| 2024-04-10 | Sale : show line 2 in the form 10b5-1 | −12,000 | $95.09 | $1,141,080 | 74,087 | D |
| Open-market sales · 12,000 sh · avg $95.09 · $1,141,080 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-10 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −12,000 | 238,000 | D |
Loading xslF345X05/ownership.xml…